Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Operating Income 2016–2025
Rhythm Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Rhythm Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -52.4 M, a 11.40% increase year-over-year.
- Rhythm Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -197.3 M, a 26.43% decrease year-over-year.
- Rhythm Pharmaceuticals Inc. annual operating income for 2025 was -192.0 M, a 27.68% decrease from 2024.
- Rhythm Pharmaceuticals Inc. annual operating income for 2024 was -265.5 M, a 44.02% increase from 2023.
- Rhythm Pharmaceuticals Inc. annual operating income for 2023 was -184.4 M, a 2.90% increase from 2022.
- Rhythm Pharmaceuticals Inc. annual operating income for 2022 was -179.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rhythm Pharmaceuticals Inc. Operating Income — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Rhythm Pharmaceuticals Inc.'s operating income?
Rhythm Pharmaceuticals Inc. (RYTM) reported operating income of -$192M for fiscal 2025.
Where can I see RYTM's operating income history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.